Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients.

NCT01224327 is registered in ClinicalTrials.gov with Qingdao University as lead sponsor.

NCT NCT01224327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01224327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients.
Lead sponsor
Qingdao University
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 31, 2010
Completion date
December 31, 2012
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis, mesenchymal stem cells, radiology, umbilical cord